咽癌放化疗后颅底或颈椎骨髓炎:严重但可治的并发症
本文报告两例局部晚期咽癌根治性放化疗后发生骨髓炎的病例,一例累及颞骨,另一例累及第2、3颈椎,经诊断和治疗后结局良好。作者建议对高剂量放疗区域新发或进展的骨改变,伴不明原因且加重的脊柱症状如疼痛和痉挛时,应将放射性骨髓炎纳入与肿瘤进展的鉴别诊断,并及时转诊外科肿瘤学家和感染病专家。
要点
- 高剂量放化疗后颅底或颈椎骨髓炎罕见但可治,需与肿瘤进展鉴别。
- 放疗区域新发骨改变伴脊柱疼痛、痉挛加重时应考虑放射性骨髓炎。
- 及时转诊外科肿瘤学家和感染病专家对获得良好结局至关重要。
核心结论
- 头颈部高剂量放化疗后颅底或颈椎骨髓炎虽罕见但可治疗,早期识别和及时干预是关键。
研究设计与样本
- 本文为两例病例报告,描述局部晚期咽癌根治性放化疗后发生骨髓炎的诊断和治疗经过。
主要发现
- 一例骨髓炎累及颞骨,另一例累及第2和第3颈椎,两例均经诊断和治疗后结局良好。
临床怎么用
- 对高剂量放疗区域新发或进展的骨改变,伴不明原因且加重的脊柱疼痛和痉挛,应将放射性骨髓炎纳入与肿瘤进展的鉴别诊断。
- 及时转诊外科肿瘤学家和感染病专家以达成满意临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteomyelitis, infection of the bone and marrow, following high dose (chemo-)radiotherapy for head and neck cancer is uncommon and rarely seen in the cervical spine or temporal bone. Due to its proximity to critical structures, osteomyelitis in the latter regions could carry potentially important consequences. Furthermore, involvement near the skull base (e.g. temporal bone and high cervical vertebrae) presents unique challenges in diagnosis (especially in the differentiation from disease recurrence) and treatment, making early detection and timely intervention critical. In this report, we describe two cases of osteomyelitis, one involving the temporal bone and the other affecting the 2nd and 3rd cervical vertebrae, diagnosed and treated with good outcome in the setting of definitive chemoradiotherapy for locally advanced pharyngeal carcinomas. We suggest that for new or evolving post-radiotherapy osseous changes in regions that have received a high dose of radiotherapy, associated with unexpected and deteriorating spinal symptoms such as pain and spasm, radiation-related osteomyelitis should be considered in the differential diagnosis from tumor progression. Timely referral to a surgical oncologist and infectious diseases specialist is paramount in achieving satisfactory clinical outcomes.
引用
- Lalani N, Huang SH, Rotstein C, et al. Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication. Clin Transl Radiat Oncol. 2017. PMID: 29594240. doi:10.1016/j.ctro.2017.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。